Fineline Cube

Follow:
14486 Articles
MicuRx Pharmaceuticals' MRX-5 Receives NMPA Approval for NTM Infections Clinical Study
CompanyDrug

MicuRx Pharmaceuticals’ MRX-5 Receives NMPA Approval for NTM Infections Clinical Study

Huahai Pharmaceutical's HB0028 and HB002.1T Cleared for Clinical Study by NMPA
CompanyDrug

Huahai Pharmaceutical’s HB0028 and HB002.1T Cleared for Clinical Study by NMPA

Hengrui Pharmaceuticals Receives NMPA Approval for HRS-6768 Clinical Trial
CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Approval for HRS-6768 Clinical Trial

China's State Council Aims to Enhance Drug and Medical Device Regulation by 2027
Policy / Regulatory

China’s State Council Aims to Enhance Drug and Medical Device Regulation by 2027

Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding
Company

Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding

AstraZeneca's Tagrisso Receives NMPA Approval for EGFR-Mutated NSCLC Treatment
CompanyDrug

AstraZeneca’s Tagrisso Receives NMPA Approval for EGFR-Mutated NSCLC Treatment

NMPA Approves Lynparza as Adjuvant Treatment for High-Risk Breast Cancer Patients
CompanyDrug

NMPA Approves Lynparza as Adjuvant Treatment for High-Risk Breast Cancer Patients

Gilead Sciences' Sunlenca Receives NMPA Approval for Multidrug-Resistant HIV-1 Infection
CompanyDrug

Gilead Sciences’ Sunlenca Receives NMPA Approval for Multidrug-Resistant HIV-1 Infection

WinHealth Pharma's Difelikefalin Receives NMPA Review for Market Approval
CompanyDrug

WinHealth Pharma’s Difelikefalin Receives NMPA Review for Market Approval

Shanghai Enacts New Regulations for Drug and Medical Device Administration
Policy / Regulatory

Shanghai Enacts New Regulations for Drug and Medical Device Administration

Thederma's TAN-118 Receives Tacit Clinical Approval from China's CDE for Global Trials
CompanyDrug

Thederma’s TAN-118 Receives Tacit Clinical Approval from China’s CDE for Global Trials

Shenzhen Hepalink Pharmaceuticals to Distribute Gabapentin in US under New Agreement
CompanyDeals

Shenzhen Hepalink Pharmaceuticals to Distribute Gabapentin in US under New Agreement